CN116905020A - Method for synthesizing 1, 3-fluoroamine product by electrochemical mode - Google Patents

Method for synthesizing 1, 3-fluoroamine product by electrochemical mode Download PDF

Info

Publication number
CN116905020A
CN116905020A CN202310437713.3A CN202310437713A CN116905020A CN 116905020 A CN116905020 A CN 116905020A CN 202310437713 A CN202310437713 A CN 202310437713A CN 116905020 A CN116905020 A CN 116905020A
Authority
CN
China
Prior art keywords
reaction
fluoroamine
product
chloroform
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310437713.3A
Other languages
Chinese (zh)
Inventor
岳燕妮
宋扬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Tech University
Original Assignee
Nanjing Tech University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Tech University filed Critical Nanjing Tech University
Priority to CN202310437713.3A priority Critical patent/CN116905020A/en
Publication of CN116905020A publication Critical patent/CN116905020A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B11/00Electrodes; Manufacture thereof not otherwise provided for
    • C25B11/04Electrodes; Manufacture thereof not otherwise provided for characterised by the material
    • C25B11/051Electrodes formed of electrocatalysts on a substrate or carrier
    • C25B11/055Electrodes formed of electrocatalysts on a substrate or carrier characterised by the substrate or carrier material
    • C25B11/057Electrodes formed of electrocatalysts on a substrate or carrier characterised by the substrate or carrier material consisting of a single element or compound
    • C25B11/061Metal or alloy
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00Electrolytic production of organic compounds
    • C25B3/01Products
    • C25B3/05Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00Electrolytic production of organic compounds
    • C25B3/01Products
    • C25B3/07Oxygen containing compounds
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00Electrolytic production of organic compounds
    • C25B3/01Products
    • C25B3/09Nitrogen containing compounds
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00Electrolytic production of organic compounds
    • C25B3/01Products
    • C25B3/11Halogen containing compounds
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00Electrolytic production of organic compounds
    • C25B3/20Processes

Abstract

The invention relates to a method for electrochemically promoting synthesis of aryl cyclopropane ring-opening 1, 3-fluoroamine products, which comprises the steps of reacting aryl cyclopropane compound with pyrazole through electrocatalytic reaction. Step one: adding aryl cyclopropane, pyrazole and tetraethylammonium tetrafluoroborate into a single-port reaction bottle with magnetons; slowly adding ultra-dry 1, 2-dichloroethane under nitrogen atmosphere, stirring at room temperature for reaction, monitoring the reaction by TLC, and stopping the reaction when the aryl cyclopropane is completely reacted; and thirdly, transferring the mixture obtained in the second step into a reaction bottle, concentrating the solvent by using a rotary evaporator, and separating and purifying the obtained crude product by using a silica gel column to obtain a corresponding 1, 3-fluoroamine product. The following advantages are achieved over the conventional method for synthesizing 1, 3-difunctional products: synthesizing to obtain a 1, 3-fluoroamine product with a single configuration; the reaction yield is higher; the method has wide application range, and can obtain a series of 1, 3-fluoroamine derivatives.

Description

Method for synthesizing 1, 3-fluoroamine product by electrochemical mode
Technical Field
The invention belongs to the field of organic chemistry, and in particular relates to a method for preparing a 1, 3-fluoroamine product.
Background
The 1, 3-fluoroamine compound widely exists in nature, and has wide application prospects in various fields such as biomedicine, organic chemical synthesis and the like. There are two main approaches to the ring-opening synthesis of 1, 3-difunctional products of non-activated cyclopropanes, one is oxidation addition depending on transition metals, but these reactions are limited to ring-opening rearrangement or cycloaddition reactions, requiring specific directing groups for regioselective ring-opening functionalization; another relies on electrophilic activation of lewis acidic species and most transformations are limited to electrophilic addition reactions only. In summary, these methods for synthesizing 1, 3-difunctional products have certain disadvantages, such as harsh reaction conditions, low product yields, long reaction times, use of toxic reagents, low regioselectivity, and the like.
Disclosure of Invention
The invention aims to provide an effective method for synthesizing a 1, 3-fluoroamine product, which solves the defects that a transition metal catalyst or Lewis acid is required to be added in the reaction process, the yield of the product is low, the chemical selectivity is low and the like in the traditional synthesis method through an electrocatalytic mode. According to the method, aryl cyclopropane and alcohols are used as raw materials through electrocatalysis, the 1, 3-fluoroamine compound with a single structure is effectively synthesized, the stability of the used reagent is high, no additional catalyst or oxidant is needed in the reaction process, the reaction time is shortened by 2-4 hours, the reaction yield is high, the reaction application range is wide, and the like.
In order to solve the technical problems of the invention, the technical proposal is as follows: a method for electrochemically synthesizing a 1, 3-fluoroamine product comprising the steps of:
step one: arylcyclopropane derivative (formula one), pyrazole and its derivative (formula two) and tetraethylammonium tetrafluoroborate are added into a drying bottle with magnetons, and a graphite positive electrode and a foam nickel negative electrode are added;
slowly adding ultra-dry 1, 2-dichloroethane under nitrogen atmosphere, introducing a direct current power supply at room temperature, stirring for reaction, and stopping the reaction when the aryl cyclopropane derivative (formula I) is completely reacted;
transferring the mixture obtained in the step two into a reaction bottle, spin-drying the solvent by using a rotary evaporator, and finally separating and purifying the obtained crude product by using a silica gel column to obtain a 1, 3-fluoroamine derivative (formula III);
the specific reaction route is as follows:
wherein R is 1 The method comprises the following steps: alkyl, halogen or ester groups; r is R 2 The method comprises the following steps: methyl, halogen, phenyl or ester groups.
Preferably, the cyclopropane derivative (formula one) is selected from various aromatic cyclopropanes.
Preferably, the pyrazoles and derivatives thereof are amine nucleophiles.
Preferably, the temperature of the reaction is 25 ℃; the reaction time is 2-4h.
Preferably, the reaction molar ratio is an arylcyclopropane derivative: pyrazole and derivatives thereof: tetraethylammonium tetrafluoroborate = 1:2:2.
preferably, the electrodes are graphite positive electrodes and nickel foam negative electrodes.
Preferably, in the second step, a direct current power supply of 5mA is supplied at room temperature and the reaction is stirred.
Preferably, the specific reaction route is as follows:
wherein R is 1 Alkyl, halogen, methoxy; r is R 2 Phenyl, halogen;
the structural formula of the target product is as follows:
preferably, the specific reaction route is as follows:
wherein R is methyl, phenyl, halogen or ester;
the specific structure of the target product is as follows:
the preparation scheme for electrocatalytic synthesis of the 1, 3-fluoroamine compound is as follows:
step one: arylcyclopropane derivatives of formula 1 (1 equiv,0.2 mmol), pyrazoles and their derivatives of formula 2 bis (2 equiv,0.4 mmol) and ammonium tetraethyltetrafluoroborate (2 equiv,0.4 mmol) were added to a dry 25ml single-necked flask with a magnet and graphite positive electrode and nickel foam negative electrode were added.
Step two: 5ml of ultra-dry organic solvent 1, 2-dichloroethane was slowly added under nitrogen atmosphere, graphite was used as anode, foam nickel was used as cathode, the reaction was stirred at 25 ℃ for 5mA under power, and monitored by TLC plate until the aryl cyclopropane derivative was completely reacted, and the reaction was stopped.
Transferring the mixture obtained in the step two into an eggplant type bottle, concentrating the solvent under low pressure by using a rotary evaporator, and finally separating and purifying the obtained crude product by using a silica gel column to obtain a corresponding 1, 3-fluoroamine product as shown in a figure III.
Formula I, formula III R 1 The method comprises the following steps: an alkyl group, a hydroxyl group,methoxy, halogen.
Formula II, formula III R 2 The method comprises the following steps: halogen, phenyl, ester group.
In the second step, the TLC plate monitors the reaction, and the reaction time is 2-4h.
The 1, 3-fluoroamine product obtained in the third step is a product with a single configuration.
Compared with the prior art, the invention has the beneficial effects that:
1. the reaction system of the invention is simple, only electrolyte tetraethyl ammonium tetrafluoroborate is needed to be added in the reaction to be used as nucleophilic fluorine source, the selected substrate is stable and easy to obtain, and the preparation cost is low.
2. The reaction system is clean, the conversion rate is higher, and the products are easy to separate.
3. The method has wide applicability, most common pyrazole derivatives are suitable for the method, the applicability of the substrate is wide, and a series of 1, 3-fluoroamine compounds can be prepared according to the method.
4. The electrolyte tetraethylammonium tetrafluoroborate used in the present invention is an electrolyte capable of providing fluoride ion. The electrolyte tetraethylammonium tetrafluoroborate used in the invention is an electrolyte which is obtained after a large amount of screening and has better capability of providing fluoride ions. The electrolyte tetraethyl ammonium tetrafluoroborate is selected to have high selectivity, can synthesize a single product of 1, 3-fluoro-oxygenated compounds, and has high yield.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below.
FIG. 1 shows nuclear magnetic resonance of 4-bromo-1- (1- (3, 4-dimethoxyphenyl) -3-fluoro-3-methylbutyl) -1-hydro-pyrazole provided in example 1 of the present invention 1 H spectrogram;
FIG. 2 shows nuclear magnetic resonance of 4-bromo-1- (1- (3, 4-dimethoxyphenyl) -3-fluoro-3-methylbutyl) -1-hydro-pyrazole provided in example 1 of the present invention 19 F, spectrogram;
FIG. 3 is a schematic illustration of 4-bromo-1- (1- (3, 4-dimethoxyphenyl) -3-fluoro-3-methyl) provided in example 1 of the present inventionNuclear magnetic resonance of phenylbutyl) -1-hydro-pyrazole 13 C, spectrogram;
FIG. 4 shows nuclear magnetic resonance of ethyl 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydro-pyrazole-4-carboxylate provided in example 1 of the present invention 1 H spectrogram;
FIG. 5 shows nuclear magnetic resonance of ethyl 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydro-pyrazole-4-carboxylate provided in example 1 of the present invention 19 F, spectrogram;
FIG. 6 shows nuclear magnetic resonance of ethyl 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydro-pyrazole-4-carboxylate provided in example 1 of the present invention 13 C, spectrogram;
FIG. 7 is a nuclear magnetic resonance of example 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydro-indazole of the present invention 1 H spectrogram;
FIG. 8 is a nuclear magnetic resonance of example 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydro-indazole of the present invention 19 F, spectrogram;
FIG. 9 is a nuclear magnetic resonance of example 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydro-indazole of the present invention 13 C spectrogram.
FIG. 10 shows nuclear magnetic resonance of 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1H-pyrazole provided in example 1 of the present invention 1 H spectrogram;
FIG. 11 shows nuclear magnetic resonance of 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1H-pyrazole provided in example 1 of the present invention 19 F, spectrogram;
FIG. 12 shows nuclear magnetic resonance of 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1H-pyrazole provided in example 1 of the present invention 13 C, spectrogram;
FIG. 13 shows nuclear magnetic resonance of 1- (3-fluoro-1- (4-methoxy-3-methylphenyl) -3-methylbutyl) -1H-pyrazole provided in example 1 of the present invention 1 H spectrogram;
FIG. 14 shows nuclear magnetic resonance of 1- (3-fluoro-1- (4-methoxy-3-methylphenyl) -3-methylbutyl) -1H-pyrazole provided in example 1 of the present invention 19 F, spectrogram;
FIG. 15 is a schematic illustration of a 1- (3-fluoro-1- (4-methoxy-3-methylphenyl) provided in example 1 of the present invention) Nuclear magnetic resonance of (E) -3-methylbutyl) -1H-pyrazole 13 C, spectrogram;
FIG. 16 shows nuclear magnetic resonance of 3-bromo-1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydro-pyrazole provided in example 1 of the present invention 1 H spectrogram;
FIG. 17 shows nuclear magnetic resonance of 3-bromo-1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydro-pyrazole provided in example 1 of the present invention 19 F, spectrogram;
FIG. 18 shows nuclear magnetic resonance of 3-bromo-1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydro-pyrazole provided in example 1 of the present invention 13 C, spectrogram;
Detailed Description
The present invention will be described in further detail with reference to the drawings and examples, in order to make the objects, technical solutions and advantages of the present invention more apparent. It should be understood that the specific embodiments described herein are for purposes of illustration only and are not intended to limit the scope of the invention.
According to the method, various types of 1, 3-fluoroamine compounds can be synthesized through the same mechanism according to different reaction substrate structures.
(1) The utility of the process is discussed using different classes of arylcyclopropane compounds with pyrazoles as template substrates. The specific reaction equation is as follows:
wherein R is 1 Is alkyl, halogen, methoxy. R is R 2 Phenyl, halogen;
the structural formula of the target product is as follows:
(2) The utility of the process is discussed using different classes of pyrazoles and derivatives thereof with 1- (2, 2-dimethylcyclopropyl) -4-methoxybenzene as a template substrate. The specific reaction equation is as follows:
wherein R is methyl, phenyl, halogen or ester.
The specific structure of the target product is as follows:
(3aN1).. 1 H NMR(400MHz,Chloroform-d):δ7.54(d,J=1.8Hz,1H),7.43(d,J=2.3Hz,1H),7.24(d,J=8.8Hz,2H),6.84(d,J=8.7Hz,2H),6.24–6.22(m,1H),5.54(dd,J=9.2,4.2Hz,1H),3.77(s,3H),3.09–2.92(m,1H),2.42(td,J=14.6,4.2Hz,1H),1.29(d,J=21.7Hz,3H),1.12(d,J=21.8Hz,3H). 19 F NMR(376MHz,Chloroform-d):δ-137.46–-137.93(m,1F). 13 C NMR(101MHz,Chloroform-d):δ159.05,139.08,133.76,128.69,127.82,113.97,105.66,94.74(d,J=166.8Hz),61.15(d,J=5.0 Hz),55.22,45.92(d,J=22.8 Hz),28.09(d,J=24.2 Hz),25.38(d,J=24.8Hz).HRMS(ESI,m/z):calcd for C 15 H 20 FN 2 O,[M+H] + :263.1560,found:263.1564.
(3aN2). 1 H NMR(401 MHz,Chloroform-d):δ7.48(s,1H),7.43(d,J=0.7 Hz,1H),7.23(d,J=8.9 Hz,2H),6.85(d,J=8.8 Hz,2H),5.48(dd,J=8.8,4.5 Hz,1H),3.78(s,3H),3.04–2.88(m,1H),2.39(td,J=15.0,4.5 Hz,1H),1.29(d,J=21.6 Hz,3H),1.16(d,J=21.7 Hz,3H). 19 F NMR(376 MHz,Chloroform-d):δ-137.94–-138.41(m,1F). 13 C NMR(101 MHz,Chloroform-d):δ159.31,139.59,132.87,128.88,127.91,114.10,94.50(d,J=166.9 Hz),93.17,61.96,55.25,45.47(d,J=23.0Hz),27.99(d,J=24.6 Hz),25.74(d,J=24.7 Hz).HRMS(ESI,m/z):calcd forC 15 H 19 BrFN 2 O,[M+H] + :341.0665,found:341.0662.
(3aN3). 1 H NMR(401 MHz,Chloroform-d):δ7.55(d,J=1.3 Hz,1H),7.29(d,J=8.7 Hz,2H),6.83(d,J=8.8 Hz,2H),6.28(d,J=1.9 Hz,1H),5.78(dd,J=9.6,3.2Hz,1H),3.77(s,3H),3.24–3.07(m,1H),2.37(td,J=14.7,3.3 Hz,1H),1.31(d,J=21.5 Hz,3H),1.10(d,J=21.7 Hz,3H). 19 F NMR(376 MHz,Chloroform-d):δ-137.54–-137.94(m,1F). 13 C NMR(101 MHz,Chloroform-d):δ159.06,139.96,133.19,128.01,113.96,112.76,108.63,94.60(d,J=166.1 Hz),58.01(d,J=4.6 Hz),55.22,45.89(d,J=22.8 Hz),28.10(d,J=24.3 Hz),25.34(d,J=24.7 Hz).HRMS(ESI,m/z):calcd for C 15 H 19 BrFN 2 O,[M+H] + :341.0665,found:341.0659.
(3aN4). 1 H NMR(400 MHz,Chloroform-d):δ7.33(s,1H),7.24–7.21(m,2H),7.20–7.18(m,1H),6.83(d,J=8.7 Hz,2H),5.44(dd,J=9.1,4.2 Hz,1H),3.77(s,3H),3.06–2.89(m,1H),2.38(td,J=14.5,4.2 Hz,1H),2.03(s,3H),1.28(d,J=21.7Hz,3H),1.14(d,J=21.8 Hz,3H). 19 F NMR(376 MHz,Chloroform-d):δ-137.24–-137.60(m,1F). 13 C NMR(101 MHz,Chloroform-d):δ158.99,139.42,134.05,127.76,127.49,116.22,113.94,94.84(d,J=166.1 Hz),60.95(d,J=5.2 Hz),55.23,45.79(d,J=23.0 Hz),28.09(d,J=24.4 Hz),25.43(d,J=24.9 Hz),8.89.HRMS(ESI,m/z):calcd for C 16 H 22 FN 2 O,[M+H] + :277.1716,found:277.1718.
(3aN5). 1 H NMR(401 MHz,Chloroform-d):δ7.93(s,2H),7.29–7.24(m,2H),6.86(d,J=8.7 Hz,2H),5.53(dd,J=8.7,4.6 Hz,1H),3.79(s,3H),3.78(s,3H),3.05–2.89(m,1H),2.42(td,J=15.3,4.6 Hz,1H),1.30(d,J=21.6 Hz,3H),1.16(d,J=21.6 Hz,3H). 19 F NMR(376 MHz,Chloroform-d):δ-138.36–-138.75(m,1F). 13 CNMR(101 MHz,Chloroform-d):δ163.38,159.44,140.87,132.41,132.13,128.05,114.77,114.19,94.37(d,J=167.3 Hz),62.02(d,J=4.7 Hz),55.27,51.31,45.56(d,J=22.7 Hz),27.92(d,J=24.4 Hz),25.88(d,J=24.7 Hz).HRMS(ESI,m/z):calcdfor C 17 H 22 FN 2 O 3 ,[M+H] + :321.1614,found:321.1612.
(3aN6). 1 H NMR(401 MHz,Chloroform-d):δ7.93(d,J=1.5 Hz,2H),7.33–7.22(m,2H),6.85(d,J=8.8 Hz,2H),5.53(dd,J=8.8,4.5 Hz,1H),4.26(q,J=7.1Hz,2H),3.77(s,3H),3.06–2.89(m,1H),2.42(td,J=15.2,4.6 Hz,1H),1.31(t,J=6.3 Hz,3H),1.30(d,J=21.5 Hz,3H),1.15(d,J=21.6 Hz,3H). 19 F NMR(376 MHz,Chloroform-d):δ-138.33–-138.71(m,1F). 13 C NMR(101 MHz,Chloroform-d):δ162.98,159.39,140.84,132.50,132.06,128.00,115.16,114.15,94.38(d,J=167.4Hz),61.96(d,J=4.7 Hz),60.13,55.25,45.54(d,J=22.6 Hz),27.93(d,J=24.4 Hz),25.82(d,J=24.6 Hz),14.33.HRMS(ESI,m/z):calcd for C 18 H 24 FN 2 O 3 ,[M+H] + :335.1771,found:335.1776.
(3aN7).0.2 mmol scale,2 h. 1 H NMR(401 MHz,Chloroform-d):δ7.98(s,1H),7.73(d,J=8.8 Hz,1H),7.60(d,J=8.4 Hz,1H),7.34(d,J=8.7 Hz,2H),7.28–7.24(m,1H),7.09–7.01(m,1H),6.84(d,J=8.8 Hz,2H),5.82(dd,J=8.6,4.6 Hz,1H),3.76(s,3H),3.28–3.12(m,1H),2.58(td,J=14.8,4.6 Hz,1H),1.31(d,J=21.6 Hz,3H),1.11(d,J=21.7 Hz,3H). 19 F NMR(376 MHz,Chloroform-d):δ-137.77–-138.11(m,1F). 13 C NMR(101 MHz,Chloroform-d):δ159.30,148.48,133.01,128.12,125.76,122.25,121.76,121.65,120.17,117.71,114.05,94.75(d,J=167.0Hz),62.95(d,J=4.8 Hz),55.25,45.98(d,J=22.6 Hz),28.11(d,J=24.2 Hz),25.55(d,J=24.6 Hz).HRMS(ESI,m/z):calcd for C 19 H 22 FN 2 O,[M+H] + :313.1716,found:313.1714.
(3aN8).0.2 mmol scale,2 h. 1 H NMR(401 MHz,Chloroform-d):δ7.98(s,1H),7.74(d,J=8.8 Hz,1H),7.60(dd,J=8.4,1.1 Hz,1H),7.29–7.23(m,2H),7.09–7.01(m,1H),6.84(d,J=7.6 Hz,1H),5.82(dd,J=8.6,4.6 Hz,2H),3.76(s,3H),2.58(td,J=14.7,4.6 Hz,1H),1.30(d,J=21.6 Hz,3H),1.11(d,J=21.7 Hz,3H). 19 FNMR(376 MHz,Chloroform-d):δ-137.71–-138.07(m,1F). 13 C NMR(101 MHz,Chloroform-d):δ159.30,148.48,133.02,128.13,125.76,122.26,121.77,121.66,120.17,117.71,114.05,94.75(d,J=167.6 Hz),62.93,55.25,45.98(d,J=22.4 Hz),28.11(d,J=24.2 Hz),25.55(d,J=24.5 Hz).HRMS(ESI,m/z):calcd forC 19 H 22 FN 2 O,[M+H] + :313.1716,found:313.1717.
(3aN9). 1 H NMR(400 MHz,Chloroform-d):δ7.87(s,1H),7.64(d,J=8.9 Hz,1H),7.34(s,1H),7.31(d,J=8.7 Hz,2H),7.11(d,J=7.3 Hz,1H),6.83(d,J=8.7Hz,2H),5.80(dd,J=8.8,4.4 Hz,1H),3.76(s,3H),3.27–3.11(m,1H),2.56(td,J=14.6,4.4 Hz,1H),2.39(s,3H),1.30(d,J=21.6 Hz,3H),1.10(d,J=21.7 Hz,3H). 19 F NMR(376 MHz,Chloroform-d):δ-137.47–-137.84(m,1F). 13 C NMR(101MHz,Chloroform-d):δ159.22,147.37,133.22,130.96,128.63,128.01,122.07,121.39,118.24,117.38,114.00,94.77(d,J=167.1 Hz),62.78(d,J=4.7 Hz),55.23,45.98(d,J=22.7 Hz),28.14(d,J=24.2 Hz),25.41(d,J=24.6 Hz),21.67.HRMS(ESI,m/z):calcd for C 20 H 24 FN 2 O,[M+H] + :327.1873,found:327.1873.
(3aN10). 1 H NMR(400 MHz,Chloroform-d):δ7.93(s,1H),7.67(d,J=8.4 Hz,1H),7.57(d,J=1.9 Hz,1H),7.34(d,J=8.8 Hz,2H),7.19(dd,J=9.1,2.0 Hz,1H),6.85(d,J=8.7 Hz,2H),5.80(dd,J=8.6,4.6 Hz,1H),3.76(s,3H),3.26–3.09(m,1H),2.57(td,J=15.0,4.6 Hz,1H),1.31(d,J=21.6 Hz,3H),1.10(d,J=21.7 Hz,3H). 19 F NMR(376 MHz,Chloroform-d):δ-138.07–-138.54(m,1F). 13 C NMR(101 MHz,Chloroform-d):δ159.36,146.77,132.61,128.10,127.28,127.10,122.09,121.92,119.23,118.86,114.08,94.60(d,J=167.2 Hz),63.12(d,J=4.5 Hz),55.22,45.86(d,J=22.5 Hz),28.01(d,J=24.4 Hz),25.59(d,J=24.6 Hz).HRMS(ESI,m/z):calcd for C 19 H 21 ClFN 2 O,[M+H] + :347.1326,found:347.1328.
(3aN11). 1 H NMR(401 MHz,Chloroform-d):δ8.45(s,1H),8.13(s,1H),7.88(dd,J=9.1,1.6 Hz,1H),7.72(d,J=9.1 Hz,1H),7.37(d,J=8.8 Hz,2H),6.86(d,J=8.8 Hz,2H),5.83(dd,J=8.4,4.8 Hz,1H),3.91(s,3H),3.76(s,3H),3.27–3.10(m,1H),2.59(td,J=15.2,4.9 Hz,1H),1.31(d,J=21.5 Hz,3H),1.11(d,J=21.7 Hz,3H). 19 F NMR(376 MHz,Chloroform-d):δ-138.31–-138.71(m,1F). 13 C NMR(101 MHz,Chloroform-d):δ167.47,159.48,149.77,132.39,128.25,125.65,124.91,124.73,123.72,121.06,117.53,114.15,94.55(d,J=167.4 Hz),63.38(d,J=4.6 Hz),55.24,52.00,45.89(d,J=22.6 Hz),27.99(d,J=24.3 Hz),25.73(d,J=24.6 Hz).HRMS(ESI,m/z):calcd for C 21 H 24 FN 2 O 3 ,[M+H] + :371.1771,found:371.1774.
(3aN12). 1 H NMR(401 MHz,Chloroform-d):δ7.71(d,J=8.8 Hz,1H),7.49(d,J=8.5 Hz,1H),7.39(d,J=8.8 Hz,2H),7.34–7.27(m,1H),7.14–7.06(m,1H),6.83(d,J=8.8 Hz,2H),6.13(dd,J=9.2,3.4 Hz,1H),3.75(s,3H),3.48–3.31(m,1H),2.54(td,J=14.8,3.4 Hz,1H),1.33(d,J=21.4 Hz,3H),1.04(d,J=21.8 Hz,3H). 19 F NMR(376 MHz,Chloroform-d):δ-137.85–-138.26(m,1F). 13 C NMR(101 MHz,Chloroform-d):δ159.20,148.14,132.60,128.31,126.71,122.36,121.93,119.38,118.16,113.98,105.84,94.68(d,J=166.9 Hz),59.57(d,J=4.3 Hz),55.21,46.01(d,J=22.6 Hz),28.15(d,J=24.2 Hz),25.41(d,J=24.7 Hz).HRMS(ESI,m/z):calcd for C 19 H 21 BrFN 2 O,[M+H] + :391.0821,found:391.0817.
(3bN1). 1 H NMR(400 MHz,Chloroform-d):δ7.55(d,J=1.9 Hz,1H),7.44(d,J=2.3 Hz,1H),7.10–6.98(m,2H),6.88(t,J=8.5 Hz,1H),6.26(t,J=2.1 Hz,1H),5.52(dd,J=9.3,3.9 Hz,1H),3.85(s,3H),3.06–2.91(m,1H),2.44–2.32(m,1H),1.30(d,J=21.6 Hz,3H),1.10(d,J=21.7 Hz,3H). 19 F NMR(376 MHz,Chloroform-d):δ-134.03–-134.11(m,1F),-138.04–-138.39(m,1F). 13 C NMR(101 MHz,Chloroform-d):δ153.39,150.94,139.34,134.71(d,J=5.8 Hz),128.85,122.31,114.52(d,J=19.4 Hz),113.25,105.88,94.62(d,J=166.6 Hz),60.71,56.21,45.84(d,J=22.7 Hz),28.21(d,J=24.3 Hz),25.21(d,J=24.9 Hz).HRMS(ESI,m/z):calcd for C 15 H 19 F 2 N 2 O,[M+H] + :281.1465,found:281.1466.
(3cN1). 1 H NMR(400 MHz,Chloroform-d):δ7.55(s,1H),7.44(d,J=2.3 Hz,1H),7.34(d,J=2.3 Hz,1H),7.17(dd,J=8.5,2.3 Hz,1H),6.85(d,J=8.5 Hz,1H),6.25(s,1H),5.51(dd,J=9.3,3.9 Hz,1H),3.86(s,3H),3.09–2.91(m,1H),2.44–2.31(m,1H),1.30(d,J=21.6 Hz,3H),1.10(d,J=21.7 Hz,3H). 19 F NMR(376MHz,Chloroform-d):δ-138.07–-138.44(m,1F). 13 C NMR(101 MHz,Chloroform-d):δ154.60,139.53,135.01,129.00,128.69,126.14,122.63,112.14,106.06,94.78(d,J=167.0 Hz),60.82,56.29,45.98(d,J=22.6 Hz),28.40(d,J=24.4 Hz),25.36(d,J=24.7 Hz).HRMS(ESI,m/z):calcd for C 15 H 19 ClFN 2 O,[M+H] + :297.1170,found:297.1169.
(3dN1). 1 H NMR(400 MHz,Chloroform-d):δ7.55(d,J=1.9 Hz,1H),7.51(d,J=2.3 Hz,1H),7.44(d,J=3.0 Hz,1H),7.22(dd,J=8.5,2.3 Hz,1H),6.82(d,J=8.5Hz,1H),6.25(t,J=2.1 Hz,1H),5.51(dd,J=9.4,3.9 Hz,1H),3.85(s,3H),3.09–2.91(m,1H),2.44–2.31(m,1H),1.30(d,J=21.6 Hz,3H),1.09(d,J=21.7 Hz,3H). 19 F NMR(376 MHz,Chloroform-d):δ-138.08–-138.44(m,1F). 13 C NMR(101MHz,Chloroform-d)δ155.35,139.37,135.31,131.58,128.83,126.77,111.85,111.70,105.90,94.60(d,J=167.2 Hz),60.56(d,J=5.0 Hz),56.24,45.87(d,J=22.7 Hz),28.24(d,J=24.4 Hz),25.21(d,J=24.7 Hz).HRMS(ESI,m/z):calcd forC 15 H 19 BrFN 2 O,[M+H] + :341.0665,found:341.0663.
(3eN1). 1 H NMR(400 MHz,Chloroform-d):δ7.47(d,J=17.3 Hz,2H),6.87–6.83(m,2H),6.81–6.78(m,1H),5.46(dd,J=9.0,4.3 Hz,1H),3.85(d,J=1.5 Hz,6H),3.07–2.90(m,1H),2.38(td,J=14.9,4.3 Hz,1H),1.30(d,J=21.5 Hz,3H),1.15(d,J=21.7 Hz,3H). 19 F NMR(376 MHz,Chloroform-d):δ-138.08–-138.45(m,1F). 13 C NMR(101 MHz,Chloroform-d):δ149.08,148.77,139.58,133.40,129.02,118.77,110.96,109.78,94.52(d,J=166.8 Hz),93.25,62.18,55.86,45.49(d,J=22.9 Hz),28.02(d,J=24.3 Hz),25.65(d,J=24.8 Hz).HRMS(ESI,m/z):calcdfor C 16 H 21 BrFN 2 O 2 ,[M+H] + :371.0770,found:371.0071.
(3fN1). 1 H NMR(401 MHz,Chloroform-d):δ7.53(d,J=1.9 Hz,1H),7.43(d,J=2.3 Hz,1H),7.13–7.07(m,2H),6.75(d,J=9.0 Hz,1H),6.23(t,J=2.1 Hz,1H),5.51(dd,J=9.2,4.1 Hz,1H),3.79(s,3H),3.09–2.92(m,1H),2.41(td,J=14.6,4.2Hz,1H),2.18(s,3H),1.28(d,J=21.7 Hz,3H),1.12(d,J=21.8 Hz,3H). 19 F NMR(376 MHz,Chloroform-d):δ-137.32–-137.72(m,1F). 13 C NMR(101 MHz,Chloroform-d):δ157.27,139.02,133.26,129.03,128.64,126.88,125.01,109.81,105.61,94.80(d,J=165.6 Hz),61.26(d,J=5.2 Hz),55.30,45.93(d,J=23.0 Hz),28.08(d,J=24.4 Hz),25.41(d,J=24.7 Hz),16.31.HRMS(ESI,m/z):calcd forC 16 H 22 FN 2 O,[M+H] + :277.1716,found:277.1715.
(3fN2). 1 H NMR(400 MHz,Chloroform-d):δ7.42(d,J=15.5 Hz,2H),7.09(d,J=6.7 Hz,2H),6.76(d,J=9.1 Hz,1H),5.41(dd,J=8.9,4.4 Hz,1H),3.80(s,3H),3.04–2.87(m,1H),2.38(td,J=15.0,4.4 Hz,1H),2.19(s,3H),1.30(d,J=21.6 Hz,3H),1.16(d,J=21.7 Hz,3H). 19 F NMR(376 MHz,Chloroform-d):δ-137.81–-138.19(m,1F). 13 C NMR(101 MHz,Chloroform-d):δ157.51,137.39,132.37,129.03,127.09,126.69,125.08,109.97,109.84,94.57(d,J=166.9 Hz),62.07(d,J=4.8 Hz),55.31,45.41(d,J=22.8 Hz),27.97(d,J=24.2 Hz),25.74(d,J=24.6 Hz),16.33.HRMS(ESI,m/z):calcd for C 16 H 21 ClFN 2 O,[M+H] + :311.1326,found:311.1329.
(3fN3). 1 H NMR(400 MHz,Chloroform-d):δ7.45(d,J=17.8 Hz,2H),7.11–7.08(m,2H),6.77–6.73(m,1H),5.44(dd,J=8.8,4.6 Hz,1H),3.80(s,3H),3.04–2.87(m,1H),2.46–2.32(m,1H),2.19(s,3H),1.29(d,J=21.6 Hz,3H),1.16(d,J=21.7 Hz,3H). 19 F NMR(376 MHz,Chloroform-d):δ-137.83–-138.19(m,1F). 13 CNMR(101 MHz,Chloroform-d):δ157.52,139.52,132.33,129.06,128.83,127.09,125.11,109.84,94.56(d,J=167.1Hz),93.11,62.05(d,J=4.8Hz),55.31,45.44(d,J=22.8Hz),27.97(d,J=24.3Hz),25.75(d,J=24.6Hz),16.33.HRMS(ESI,m/z):calcd for C 16 H 21 BrFN 2 O,[M+H] + :355.0821,found:355.0821.
(3fN4). 1 H NMR(400MHz,Chloroform-d):δ7.98(s,1H),7.74(d,J=8.6Hz,1H),7.60(d,J=7.2Hz,1H),7.30–7.18(m,3H),7.09–7.01(m,1H),6.75(d,J=9.1Hz,1H),5.79(dd,J=8.7,4.6Hz,1H),3.78(s,3H),3.28–3.11(m,1H),2.58(td,J=14.8,4.6Hz,1H),2.18(s,3H),1.30(d,J=21.6Hz,3H),1.11(d,J=21.7Hz,3H). 19 F NMR(376MHz,Chloroform-d):δ-137.52–-137.88(m,1F). 13 C NMR(101MHz,Chloroform-d):δ157.50,148.43,132.45,129.26,126.99,125.68,125.34,122.18,121.77,121.59,120.17,117.72,109.80,94.79(d,J=167.1Hz),63.07,55.30,45.93(d,J=22.5Hz),28.08(d,J=24.3Hz),25.56(d,J=24.6Hz),16.30.HRMS(ESI,m/z):calcd for C 20 H 24 FN 2 O,[M+H] + :327.1873,found:327.1871.
(3uN1). 1 H NMR(400MHz,Chloroform-d):δ7.46(d,J=22.1Hz,2H),7.29(d,J=8.7Hz,2H),6.86(d,J=8.7Hz,2H),5.43(dd,J=8.6,5.4Hz,1H),3.78(s,3H),3.07–2.90(m,1H),2.59–2.41(m,1H),2.28–1.99(m,3H),1.94–1.70(m,3H). 19 FNMR(376MHz,Chloroform-d):δ-134.82–-135.11(m,1F). 13 C NMR(101MHz,Chloroform-d):δ159.40,139.81,132.16,129.35,128.23,114.04,96.28(d,J=210.1Hz),92.82,61.57(d,J=3.8Hz),55.26,41.90(d,J=22.0Hz),34.23(d,J=21.6Hz),32.64(d,J=21.8Hz),12.14(d,J=11.8Hz).HRMS(ESI,m/z):calcd for C 16 H 19 BrFN 2 O,[M+H] + :353.0665,found:353.0664.
example 1
This example is directed to the preparation of 4-bromo-1- (1- (3, 4-dimethoxyphenyl) -3-fluoro-3-methylbutyl) -1-hydro-pyrazole. The specific operation is as follows:
/>
under nitrogen atmosphere, 1- (2, 2-dimethylcyclopropyl) -3, 4-dimethoxybenzene (0.2 mmol), 4-bromopyrazole (0.4 mmol), tetraethylammonium tetrafluoroborate (0.4 mmol) and ultra-dry 1, 2-dichloroethane (5 ml) were added to a single-port reaction flask equipped with a magnet in an IKA electrochemical apparatus using graphite as anode and nickel foam as cathode. The reaction was carried out at room temperature by applying 5 mA. The reaction was monitored using TLC plates until complete reaction of 1- (2, 2-dimethylcyclopropyl) -3, 4-dimethoxybenzene. The reaction solvent was transferred to a reaction flask, and the solvent was concentrated using a rotary evaporator to obtain a crude product. The crude product was purified by silica gel column chromatography (2% ea/PE) to give the desired product 4-bromo-1- (1- (3, 4-dimethoxyphenyl) -3-fluoro-3-methylbutyl) -1-hydro-pyrazole as a colourless oil in 38% yield.
Determination of 4-bromo-1- (1- (3, 4-dimethoxyphenyl) -3-fluoro-3-methylbutyl) -1-hydro-pyrazole nuclear magnetic resonance hydrogen spectrum gave the following results: 1 H NMR(400MHz,Chloroform-d):δ7.47(d,J=17.3Hz,2H),6.87–6.83(m,2H),6.81–6.78(m,1H),5.46(dd,J=9.0,4.3Hz,1H),3.85(d,J=1.5Hz,6H),3.07–2.90(m,1H),2.38(td,J=14.9,4.3Hz,1H),1.30(d,J=21.5Hz,3H),1.15(d,J=21.7Hz,3H).
determination of the nuclear magnetic resonance fluorine spectrum of 4-bromo-1- (1- (3, 4-dimethoxyphenyl) -3-fluoro-3-methylbutyl) -1-hydro-pyrazole gave the following results: 19 F NMR(376MHz,Chloroform-d):δ-138.08–-138.45(m,1F).
determination of the nuclear magnetic resonance carbon spectrum of 4-bromo-1- (1- (3, 4-dimethoxyphenyl) -3-fluoro-3-methylbutyl) -1-hydro-pyrazole gave the following results: 13 C NMR(101MHz,Chloroform-d):δ149.08,148.77,139.58,133.40,129.02,118.77,110.96,109.78,94.52(d,J=166.8Hz),93.25,62.18,55.86,45.49(d,J=22.9Hz),28.02(d,J=24.3Hz),25.65(d,J=24.8Hz).
example 2
This example is directed to the preparation of 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydro-pyrazole-4-carboxylic acid ethyl ester. The specific operation is as follows:
under nitrogen atmosphere, 1- (2, 2-dimethylcyclopropyl) -4-methoxybenzene (0.2 mmol), ethyl 4-pyrazolecarboxylate (0.4 mmol), tetraethylammonium tetrafluoroborate (0.4 mmol) and ultra-dry 1, 2-dichloroethane (5 ml) were added to a single-port reaction flask equipped with a magnet in an IKA electrochemical apparatus using graphite as anode and nickel foam as cathode. The reaction was carried out at room temperature by applying 5 mA. The reaction was monitored using TLC plates until complete reaction of 1- (2, 2-dimethylcyclopropyl) -4-methoxybenzene. The reaction solvent was transferred to a reaction flask, and the solvent was concentrated using a rotary evaporator to obtain a crude product. The crude product was purified by silica gel column chromatography (1% ea/PE) to give the desired product ethyl 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydro-pyrazole-4-carboxylate as colorless oily liquid in 76% yield.
Determination of nuclear magnetic resonance hydrogen spectrum of ethyl 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydro-pyrazole-4-carboxylate gave the following results: 1 H NMR(400MHz,Chloroform-d):δ7.93(d,J=1.5Hz,2H),7.33–7.22(m,2H),6.85(d,J=8.8Hz,2H),5.53(dd,J=8.8,4.5Hz,1H),4.26(q,J=7.1Hz,2H),3.77(s,3H),3.06–2.89(m,1H),2.42(td,J=15.2,4.6Hz,1H),1.31(t,J=6.3Hz,3H),1.30(d,J=21.5Hz,3H),1.15(d,J=21.6Hz,3H).
the nuclear magnetic resonance fluorine spectrum of the ethyl 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydro-pyrazole-4-carboxylate is determined as follows: 19 F NMR(376MHz,Chloroform-d):δ-138.33–-138.71(m,1F).
the nuclear magnetic resonance carbon spectrum of 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydro-pyrazole-4-carboxylic acid ethyl ester is measured, and the result is that: 13 C NMR(101MHz,Chloroform-d):δ162.98,159.39,140.84,132.50,132.06,128.00,115.16,114.15,94.38(d,J=167.4Hz),61.96(d,J=4.7Hz),60.13,55.25,45.54(d,J=22.6Hz),27.93(d,J=24.4Hz),25.82(d,J=24.6Hz),14.33.
example 3
This example proceeds to the preparation of 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydro-indazole. The specific operation is as follows:
under nitrogen atmosphere, 1- (2, 2-dimethylcyclopropyl) -4-methoxybenzene (0.2 mmol), indazole (0.4 mmol), tetraethylammonium tetrafluoroborate (0.4 mmol) and ultra-dry 1, 2-dichloroethane (5 ml) were added to a single-port reaction flask equipped with a magneton in an IKA electrochemical apparatus using graphite as anode and nickel foam as cathode. The reaction was carried out at room temperature by applying 5 mA. The reaction was monitored using TLC plates until complete reaction of 1- (2, 2-dimethylcyclopropyl) -4-methoxybenzene. The reaction solvent was transferred to a reaction flask, and the solvent was concentrated using a rotary evaporator to obtain a crude product. The crude product was purified by silica gel column chromatography (2% ea/PE) to give the desired product 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydro-indazole as a colourless oily liquid in 40% yield.
Determination of 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydro-indazole nuclear magnetic resonance hydrogen spectrum gave the following results: 1 H NMR(400MHz,Chloroform-d):δ7.98(s,1H),7.74(d,J=8.8Hz,1H),7.60(dd,J=8.4,1.1Hz,1H),7.29–7.23(m,2H),7.09–7.01(m,1H),6.84(d,J=7.6Hz,1H),5.82(dd,J=8.6,4.6Hz,2H),3.76(s,3H),2.58(td,J=14.7,4.6Hz,1H),1.30(d,J=21.6Hz,3H),1.11(d,J=21.7Hz,3H).
determination of 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydro-indazole nuclear magnetic resonance fluorine spectrum gave the following results: 19 F NMR(376MHz,Chloroform-d):δ-137.71–-138.07(m,1F).
determination of 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydro-indazole nuclear magnetic resonance carbon spectrum gave the following results: 13 C NMR(101MHz,Chloroform-d):δ159.30,148.48,133.02,128.13,125.76,122.26,121.77,121.66,120.17,117.71,114.05,94.75(d,J=167.6Hz),62.93,55.25,45.98(d,J=22.4Hz),28.11(d,J=24.2Hz),25.55(d,J=24.5Hz).
example 4
Under nitrogen atmosphere, 1- (2, 2-dimethylcyclopropyl) -4-methoxybenzene (0.2 mmol), pyrazole (0.4 mmol), tetraethylammonium tetrafluoroborate (0.4 mmol) and ultra-dry 1, 2-dichloroethane (5 ml) were added to a single-port reaction flask equipped with a magneton in an IKA electrochemical apparatus using graphite as anode and nickel foam as cathode. The reaction was carried out at room temperature by applying 5 mA. The reaction was monitored using TLC plates until complete reaction of 1- (2, 2-dimethylcyclopropyl) -4-methoxybenzene. The reaction solvent was transferred to a reaction flask, and the solvent was concentrated using a rotary evaporator to obtain a crude product. The crude product was purified by silica gel column chromatography (2% ea/PE) to give the desired product 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1 h-pyrazole as a colourless oily liquid in 57% yield.
The nuclear magnetic resonance hydrogen spectrum of 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1 hydrogen-pyrazole was measured, and the result is: 1 H NMR(400MHz,Chloroform-d):δ7.54(d,J=1.8Hz,1H),7.43(d,J=2.3Hz,1H),7.24(d,J=8.8Hz,2H),6.84(d,J=8.7Hz,2H),6.24–6.22(m,1H),5.54(dd,J=9.2,4.2Hz,1H),3.77(s,3H),3.09–2.92(m,1H),2.42(td,J=14.6,4.2Hz,1H),1.29(d,J=21.7Hz,3H),1.12(d,J=21.8Hz,3H).
the nuclear magnetic resonance fluorine spectrum of 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydrogen-pyrazole was measured, and the result is: 19 F NMR(376MHz,Chloroform-d):δ-137.46–-137.93(m,1F).
the nuclear magnetic resonance spectrum of 1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1-hydrogen-pyrazole was measured, and the result is: 13 C NMR(101MHz,Chloroform-d):δ159.05,139.08,133.76,128.69,127.82,113.97,105.66,94.74(d,J=166.8Hz),61.15(d,J=5.0Hz),55.22,45.92(d,J=22.8Hz),28.09(d,J=24.2Hz),25.38(d,J=24.8Hz).
example 5
Under nitrogen atmosphere, 1- (2, 2-dimethylcyclopropyl) -3-methyl-4-methoxybenzene (0.2 mmol), pyrazole (0.4 mmol), tetraethylammonium tetrafluoroborate (0.4 mmol) and ultra-dry 1, 2-dichloroethane (5 ml) were charged into a single-port reaction flask equipped with a magneton in an IKA electrochemical apparatus using graphite as anode and nickel foam as cathode. The reaction was carried out at room temperature by applying 5 mA. The reaction was monitored using TLC plates until complete reaction of 1- (2, 2-dimethylcyclopropyl) -3-methyl-4-methoxybenzene. The reaction solvent was transferred to a reaction flask, and the solvent was concentrated using a rotary evaporator to obtain a crude product. The crude product was purified by silica gel column chromatography (2% ea/PE) to give the desired product 1- (3-fluoro-1- (4-methoxy-3-methylphenyl) -3-methylbutyl) -1 h-pyrazole as a colourless oily liquid in 60% yield.
Para-1- (3-fluoro-1- (4-methoxy-3-methylphenyl) -3-methylbutyl)Determination of the hydrogen nuclear magnetic resonance spectrum of the radical) -1 hydrogen-pyrazole, the result is as follows: 1 H NMR(400MHz,Chloroform-d):δ7.53(d,J=1.9Hz,1H),7.43(d,J=2.3Hz,1H),7.13–7.07(m,2H),6.75(d,J=9.0Hz,1H),6.23(t,J=2.1Hz,1H),5.51(dd,J=9.2,4.1Hz,1H),3.79(s,3H),3.09–2.92(m,1H),2.41(td,J=14.6,4.2Hz,1H),2.18(s,3H),1.28(d,J=21.7Hz,3H),1.12(d,J=21.8Hz,3H).
the nuclear magnetic resonance fluorine spectrum of 1- (3-fluoro-1- (4-methoxy-3-methylphenyl) -3-methylbutyl) -1 hydrogen-pyrazole was measured, and the result is: 19 F NMR(376MHz,Chloroform-d):δ-137.32–-137.72(m,1F).
the nuclear magnetic resonance spectrum of 1- (3-fluoro-1- (4-methoxy-3-methylphenyl) -3-methylbutyl) -1 hydrogen-pyrazole was measured, and the result is: 13 C NMR(101MHz,Chloroform-d):δ157.27,139.02,133.26,129.03,128.64,126.88,125.01,109.81,105.61,94.80(d,J=165.6Hz),61.26(d,J=5.2Hz),55.30,45.93(d,J=23.0Hz),28.08(d,J=24.4Hz),25.41(d,J=24.7Hz),16.31.
example 6
Under nitrogen atmosphere, 1- (2, 2-dimethylcyclopropyl) -4-methoxybenzene (0.2 mmol), pyrazole (0.4 mmol), tetraethylammonium tetrafluoroborate (0.4 mmol) and ultra-dry 1, 2-dichloroethane (5 ml) were added to a single-port reaction flask equipped with a magneton in an IKA electrochemical apparatus using graphite as anode and nickel foam as cathode. The reaction was carried out at room temperature by applying 5 mA. The reaction was monitored using TLC plates until complete reaction of 1- (2, 2-dimethylcyclopropyl) -4-methoxybenzene. The reaction solvent was transferred to a reaction flask, and the solvent was concentrated using a rotary evaporator to obtain a crude product. The crude product was purified by silica gel column chromatography (2% ea/PE) to give the desired product 3-bromo-1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1 h-pyrazole as a colourless oily liquid in 59% yield.
The nuclear magnetic resonance hydrogen spectrum of 3-bromo-1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1 hydrogen-pyrazole was measured, and the result is: 1 H NMR(400MHz,Chloroform-d):δ7.55(d,J=1.3Hz,1H),7.29(d,J=8.7Hz,2H),6.83(d,J=8.8Hz,2H),6.28(d,J=1.9Hz,1H),5.78(dd,J=9.6,3.2Hz,1H),3.77(s,3H),3.24–3.07(m,1H),2.37(td,J=14.7,3.3Hz,1H),1.31(d,J=21.5Hz,3H),1.10(d,J=21.7Hz,3H).
the nuclear magnetic resonance fluorine spectrum of 3-bromo-1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1 hydrogen-pyrazole was measured, and the result is: 19 F NMR(376MHz,Chloroform-d):δ-137.54–-137.94(m,1F).
the nuclear magnetic resonance spectrum of 3-bromo-1- (3-fluoro-1- (4-methoxyphenyl) -3-methylbutyl) -1 hydrogen-pyrazole was measured, and the result is: 13 C NMR(101MHz,Chloroform-d):δ59.06,139.96,133.19,128.01,113.96,112.76,108.63,94.60(d,J=166.1Hz),58.01(d,J=4.6Hz),55.22,45.89(d,J=22.8Hz),28.10(d,J=24.3Hz),25.34(d,J=24.7Hz).
comparative example 1
This comparative example is compared with the preparation of 1- (3-fluoro-1-methoxy-3-methylbutyl) -4-methoxybenzene according to the following procedure:
under nitrogen atmosphere, 1- (2, 2-dimethylcyclopropyl) -3, 4-dimethoxybenzene (0.2 mmol), 4-bromopyrazole (0.4 mmol), tetraethylammonium tetrafluoroborate (0.4 mmol) and ultra-dry tetrahydrofuran (5 ml) were added to a single-port reaction flask equipped with a magnet in an IKA electrochemical apparatus using graphite as anode and nickel foam as cathode. The reaction was carried out at room temperature by applying 5 mA. The reaction was monitored using TLC plates and no formation of the target product was observed.
The foregoing description of the preferred embodiments of the invention is not intended to be limiting, but rather is intended to cover all modifications, equivalents, and alternatives falling within the spirit and principles of the invention.

Claims (9)

1. A method for electrochemically synthesizing a 1, 3-fluoroamine product, comprising the steps of:
step one: arylcyclopropane derivative (formula one), pyrazole and its derivative (formula two) and tetraethylammonium tetrafluoroborate are added into a drying bottle with magnetons, and a graphite positive electrode and a foam nickel negative electrode are added;
slowly adding ultra-dry 1, 2-dichloroethane under nitrogen atmosphere, introducing a direct current power supply at room temperature, stirring for reaction, and stopping the reaction when the aryl cyclopropane derivative (formula I) is completely reacted;
transferring the mixture obtained in the step two into a reaction bottle, spin-drying the solvent by using a rotary evaporator, and finally separating and purifying the obtained crude product by using a silica gel column to obtain a 1, 3-fluoroamine derivative (formula III);
the specific reaction route is as follows:
wherein R is 1 The method comprises the following steps: alkyl, halogen or ester groups; r is R 2 The method comprises the following steps: methyl, halogen, phenyl or ester groups.
2. The method for electrochemically synthesizing a 1, 3-fluoroamine product of claim 1, wherein the cyclopropane derivative (formula one) is selected from a variety of aromatic cyclopropanes.
3. The method for electrochemically synthesizing a 1, 3-fluoroamine product of claim 1, wherein the pyrazole and derivatives thereof are amine nucleophiles.
4. The method for electrochemically synthesizing a 1, 3-fluoroamine product of claim 1, wherein the temperature of the reaction is 25 ℃; the reaction time is 2-4h.
5. The method for electrochemically synthesizing a 1, 3-fluoroamine product of claim 1, wherein the reaction molar ratio is an arylcyclopropane derivative: pyrazole and derivatives thereof: tetraethylammonium tetrafluoroborate = 1:2:2.
6. the method for electrochemically synthesizing a 1, 3-fluoroamine product of claim 1, wherein the electrodes are a graphite positive electrode and a nickel foam negative electrode.
7. The method for electrochemically synthesizing a 1, 3-fluoroamine product of claim 1, wherein in step two, a 5mA dc power source is applied at room temperature and the reaction is stirred.
8. The method for electrochemically synthesizing a 1, 3-fluoroamine product of claim 1, wherein the specific reaction scheme is as follows:
wherein R is 1 Alkyl, halogen, methoxy; r is R 2 Phenyl, halogen;
the structural formula of the target product is as follows:
9. the method for electrochemically synthesizing a 1, 3-fluoroamine product of claim 1, wherein: the specific reaction route is as follows:
wherein R is methyl, phenyl, halogen or ester;
the specific structure of the target product is as follows:
CN202310437713.3A 2023-04-21 2023-04-21 Method for synthesizing 1, 3-fluoroamine product by electrochemical mode Pending CN116905020A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310437713.3A CN116905020A (en) 2023-04-21 2023-04-21 Method for synthesizing 1, 3-fluoroamine product by electrochemical mode

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310437713.3A CN116905020A (en) 2023-04-21 2023-04-21 Method for synthesizing 1, 3-fluoroamine product by electrochemical mode

Publications (1)

Publication Number Publication Date
CN116905020A true CN116905020A (en) 2023-10-20

Family

ID=88363462

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310437713.3A Pending CN116905020A (en) 2023-04-21 2023-04-21 Method for synthesizing 1, 3-fluoroamine product by electrochemical mode

Country Status (1)

Country Link
CN (1) CN116905020A (en)

Similar Documents

Publication Publication Date Title
Gao et al. Visible-light photoredox synthesis of internal alkynes containing quaternary carbons
CN106906486B (en) The electrochemical method for synthesizing of the bromo- 2- phenyl imidazole of 3- simultaneously [1,2- α] pyridine derivatives
CN111676487B (en) Method for preparing 2-aminoindole compound through electrooxidation amination
CN114892187B (en) Method for electrochemically synthesizing imidazole polycyclic aromatic compounds
CN114525527A (en) Electrochemical synthesis method of sultam derivative
Hongyu et al. Electrochemical Multicomponent Synthesis of α-Ketoamides from α-Oxocarboxylic Acids, Isocyanides and Water
CN111304684A (en) Method for preparing benzimidazolone through electrocatalysis
CN113200914A (en) Alkynylated tetrahydroisoquinoline compound and preparation method and application thereof
CN116905020A (en) Method for synthesizing 1, 3-fluoroamine product by electrochemical mode
Yuan et al. Electrocatalytic Annulation–Iodosulfonylation of Indole‐Tethered 1, 6‐Enynes to Access Pyrrolo [1, 2‐a] indoles
CN113957461A (en) Electrochemical synthesis method of 1,1' -binaphthyl compound
CN111575731B (en) Method for electrochemically synthesizing C5 and C7 dihalogenated quinoline amide derivatives
CN111155141B (en) Method for electrochemically synthesizing gem-difluoroolefin
Feng et al. Aryl-iodide-mediated electrochemical aziridination of electron-deficient alkenes
CN114438523A (en) Green and efficient electrochemical synthesis method of benzothiophene compound
CN116905005A (en) Method for synthesizing 1, 3-oxyfluoride product by electrochemical mode
Ma et al. Synthesis of 2-alkyl triazoles with solvothermal conditions
CN113862708B (en) Method for electrochemically synthesizing beta-cyano bis-benzenesulfonimide compound
CN111945181B (en) Electrochemical synthesis method of 3-alkylselenoquinolinone compound
CN113981475A (en) Electrochemical method for preparing N-alkyl sulfoxide imide
CN112126941B (en) Polysubstituted 10-hydroxy phenanthrene derivative and preparation method thereof
CN117403251A (en) Method for electrochemically synthesizing 1-position unsubstituted imidazo [1,5-a ] pyridine compound
CN109518211A (en) A kind of electrochemical method for synthesizing of the even acyl class compound of fragrance
JP5121346B2 (en) Optically active proline ester derivative and method for producing N-formyl optically active proline derivative
CN115747843A (en) Electrochemical preparation method for synthesizing fluoroisoquinoline-1,3-diketone compound through trifluoromethylation/cyclization

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination